DUPILUMAB TREATMENT REDUCES HOSPITALIZATIONS IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF DATA FROM 7 RANDOMIZED, PLACEBO-CONTROLLED STUDIES

被引：0
|
作者：
Silverberg, J. [1 ]
Rubini, N. [2 ]
Pires, M. C. [3 ]
Rossi, A. [4 ]
Zhang, A. [4 ]
Chen, Z. [5 ]
Levit, N. A. [5 ]
Thomas, R. [5 ]
Shumel, B. [5 ]
Bego, G. [6 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[2] Fed Univ State Rio De Janeiro, Rio De Janeiro, Brazil
[3] Hosp Serv Publ Estadual Sao Paulo, Sao Paulo, Brazil
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Regeneron Pharmaceut Inc, Greenwich, CT USA
[6] Sanofi, Chilly Mazarin, France
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSA13
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    de Bruin-Weller, Marjolein S.
    Serra-Baldrich, Esther
    Barbarot, Sebastien
    Grond, Susanne
    Schuster, Christopher
    Petto, Helmut
    Capron, Jean-Philippe
    Raibouaa, Afaf
    Werfel, Thomas
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1481 - 1491
  • [22] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [23] Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
    Awosika, Olabola
    Kim, Lori
    Mazhar, Momina
    Rengifo-Pardo, Monica
    Ehrlich, Alison
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 : 41 - 49
  • [24] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Zhao, Yan
    Wu, Liming
    Lu, Qianjin
    Gao, Xinghua
    Zhu, Xiaohong
    Yao, Xu
    Li, Linfeng
    Li, Wei
    Ding, Yangfeng
    Song, Zhiqiang
    Liu, Lingling
    Dang, Ningning
    Zhang, Chunlei
    Liu, Xiaoming
    Gu, Jun
    Wang, Jinyan
    Geng, Songhai
    Liu, Qunazhong
    Guo, Yifeng
    Lv, Dong
    Ren, Gong
    Yang, Xiumin
    Deng, Danqi
    Li, Shanshan
    Han, Xiuping
    Biao, Shuzhen
    Zheng, Min
    Dong, Li
    Su, Huijuan
    Bai, Lili
    O'Malley, John T.
    Luo, Junxiang
    Zhang, Jianzhong
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
  • [25] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
  • [26] EFFICACY AND SAFETY OF DUPILUMAB MONOTHERAPY IN CHINESE ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RATIONALE AND DESIGN OF A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE III TRIAL
    Zhao, Yan
    Lu, Qianjin
    Gao, Xinghua
    Liu, Lingling
    Li, Wei
    Song, Zhiqiang
    Yao, Zhirong
    Yao, Xu
    Hao, Nan
    Zhang, Jianzhong
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 52 - 53
  • [27] Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
    Jonathan I. Silverberg
    Charles W. Lynde
    Katrina Abuabara
    Cataldo Patruno
    Anna de Benedetto
    Haixin Zhang
    Ryan B. Thomas
    Gaëlle Bégo-Le-Bagousse
    Faisal A. Khokhar
    Jignesh Vakil
    Ainara Rodríguez Marco
    Noah A. Levit
    [J]. American Journal of Clinical Dermatology, 2023, 24 : 673 - 673
  • [28] Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies
    Staender, Sonja
    Bhatia, Neal
    Gooderham, Melinda J.
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Biswas, Pinaki
    DiBonaventura, Marco
    Romero, William
    Farooqui, Saleem A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB148 - AB148
  • [29] Dupilumab with concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: A randomised, placebo-controlled phase 3 clinical trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Zhu, X.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 55 - 55
  • [30] Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    Costanzo, Antonio
    Foley, Peter
    Ardeleanu, Marius
    Wu, Jiangming
    Ozturk, Zafer E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
12345